About CardioAbstracts
HFSA’s Cardio Abstracts program delivers expert-led discussions on recently presented clinical trial data in a convenient, interactive format. This 45-minute live seminar features Q&A with leading clinicians, recordings, and downloadable resources available for on-demand learning. This program is designed to support diverse learning styles and provide practical insights for clinicians specializing in heart failure care.
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) is a complex disease characterized by amyloid fibril deposition in the heart. Current and emerging advances in disease-modifying therapies for this disease that will change clinical practice are evolving rapidly. Interact with HFSA faculty as they review and answer questions about the recently presented clinical trial data and how these findings may impact patient care.
Moderator: Daniel P. Judge, MD, FACC, FHFSA
Professor of Medicine/Cardiology
Medical University of South Carolina
Director of Cardiovascular Genetics
Fellowship Director, General Cardiology Section of Advanced HF & Transplant Cardiology
Charleston, South Carolina
Speaker: Kevin M. Alexander, MD, FACC, FHFSA
Stanford Amyloid Center
Assistant Professor of Medicine
Stanford University
Palo Alto, California
Speaker: Nitasha Sarswat, MD
Assistant Professor of Medicine
Director, Infiltrative Cardiomyopathy Program
The University of Chicago Medicine
Chicago, IL
Speaker: Ahmad Masri, MD, MS
Cardiomyopathy Section Head
Director, Hypertrophic Cardiomyopathy Center and Cardiac Amyloidosis Program
Associate Professor of Medicine
Oregon Health & Science University
Portland, Oregon
This program was supported by an Independent Medical Education Grant from BridgeBio Pharma, Inc.
Cardiologists, interventional cardiologists, primary care physicians, cardiac surgeons, internists, nurse practitioners, nurse practitioners, physician assistants, nurses, pharmacists, and other health care providers who care for patients with heart failure.
CardioAbstracts is a non-accredited educational program that utilizes an online format to provide timely information and the opportunity to interact with faculty and ask questions to find more information about recent clinical trial data in amyloidosis.